Publicaciones en colaboración con investigadores/as de University of Milan (17)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Improved estimation of the risk of manic relapse by combining clinical and brain scan data

    Revista de Psiquiatria y Salud Mental

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2016

  1. The global spread of HIV-1 subtype B epidemic

    Infection, Genetics and Evolution, Vol. 46, pp. 169-179

2014

  1. Estimating the glomerular filtration rate in the Spanishworking population: Chronic kidney disease prevalence and its associationwith risk factors

    Journal of Hypertension, Vol. 32, Núm. 10, pp. 1970-1978

  2. Influence of high cardiovascular risk in asymptomatic people on the duration and cost of sick leave: Results of the ICARIA study

    European Heart Journal, Vol. 35, Núm. 5, pp. 299-306

2013

  1. Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study

    BMC Infectious Diseases, Vol. 13, Núm. 1

2012

  1. Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients

    Retrovirology, Vol. 9

2011

  1. The state of hepatitis B and C in Europe: Report from the hepatitis B and C summit conference

    Journal of Viral Hepatitis, Vol. 18, Núm. SUPPL. 1, pp. 1-16

2009

  1. Tracing the HIV-1 subtype B mobility in Europe: A phylogeographic approach

    Retrovirology, Vol. 6

  2. Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal

    Clinical Infectious Diseases, Vol. 48, Núm. 8, pp. 1138-1151

2006

  1. The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes

    Journal of Acquired Immune Deficiency Syndromes, Vol. 41, Núm. 3, pp. 352-360

2005

  1. Addressing current challenges in haemophilia care: Consensus recommendations of a European Interdisciplinary Working Group

    Haemophilia, Vol. 11, Núm. 5, pp. 433-437

  2. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management

    Journal of Infectious Diseases, Vol. 192, Núm. 6, pp. 958-966

2004

  1. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes

    Lancet, Vol. 364, Núm. 9428, pp. 51-62

1996

  1. Nucleotide sequence and restriction fragment-length polymorphism analysis of human T-cell lymphotropic virus type II (HTLV-II) in Southern Europe: Evidence for the HTLV-IIa and HTLV-IIb subtypes

    Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, Vol. 13, Núm. 4, pp. 384-391